AI News about us biotech

Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts | Health

Grifols Plans US Biotech IPO, Maintains Majority Control Spanish pharmaceutical giant Grifols is taking its US biopharma division public through an initial public offering while retaining majority ownership. The company will float a minority stake, allowing it to raise capital while keeping strategic control. This move reflects growing trends of healthcare companies restructuring to optimize valuations.